Pharmaceutical Technology Excellence Awards 2021 – Guidelines
Welcome to the Pharmaceutical Technology 2021 Excellence Awards.
SUBMISSION DEADLINE – FRIDAY JULY 30
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the industry. The Awards provide a platform to recognise the people and companies that are driving change.
Our award programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
Alongside the awards we will also be publishing a downloadable report reviewing the last 12 months, which will include:
- Excellence Award shortlists and winners
- GlobalData tables of M&A deal value and volume in the sector
- Thought leadership articles covering hot topics from the last 12 months
If you would like to contribute an article to the report please contact our commercial team.
How our submission process works
All relevant organisations within the sector are invited to submit case studies for the awards, which highlight their excellence in the sector.
Case studies can be submitted for the following types of initiatives:
- Business expansion
- COVID-19 response
- Diversity initiatives
- Environmental initiatives
- Product launches and R&D
- Safety initiatives
- Social and community initiatives
*For more detailed examples please see appendix
Companies should aim to submit ONE outstanding case study for each of the above categories they wish to submit for. Case studies can be tagged in multiple categories.
Case studies must only include active projects in the period from July 1 2020.
For each case study you should explain the aims, challenges, methods and outcome of the project/initiative.
Case studies will be taken into consideration for all relevant awards, e.g. a diversity initiative will be considered for the specific diversity award as well as the broader sector awards.
In addition to company submissions our research team undertakes independent research into the market, including using the GlobalData datasets to ensure we are aware of the most notable projects, deals and initiatives.
- Research begins – June 2021
- Case study submission deadline – Friday July 30th
- Shortlists announced – November 2021
- Winners announced – December 2021
How we use your case studies – publication
If your company is shortlisted for an award we will publish a short summary stating our reasoning. PLEASE NOTE – This may include details of your submitted case studies unless you indicate otherwise.
If you wish to submit case studies that are NOT for publication please indicate this using the checkbox in the individual case studies.
If only elements of the case study are confidential then please mark this clearly in the case study description.
Our awards are divided into four main groups. Case studies submitted will be taken into consideration for all relevant award categories.
COVID-19 RESPONSE – DIVERSITY – ENVIRONMENTAL IMPACT – INNOVATION – PRODUCT LAUNCH & R&D – SAFETY – SOCIAL IMPACT
CARDIOVASCULAR – CENTRAL NERVOUS SYSTEM – CLINICAL TRIALS – DRUG DEVELOPMENT – IMMUNOLOGY – INFECTIOUS DISEASES – MANUFACTURING – ONCOLOGY – RESPIRATORY – SUPPLY CHAIN
Firms of the Year
DISRUPTOR – FINANCE – LEGAL – NEWCOMER – PRIVATE EQUITY/VC – SME
Deals of the Year
M&A (Impact) – M&A (Innovation) – FINANCE
People of the Year
MVP – MVP (Legal) – YOUNG GUN – YOUNG GUN (Legal)
Within each award category, alongside the shortlisted companies and eventual winners we will also recognise the ‘Best In Class’ companies in each region and market.
All relevant case studies count towards a company’s scorecard. The scorecard is the primary factor in determining the shortlists for each award.
To become a shortlisted entity a company’s score must be higher or equal to a certain threshold.
Some categories will only take into account a company’s scores for a specific attribute, others, such as the Sector Excellence awards will look at a company’s scores across the board.
We use a scoring system in order that the case studies under consideration are judged on merit and not on the reputation of the companies involved.
The winners in each category are determined by an editorial panel who look at the scores, case studies and broader market context when making their decision.
To ensure that all awards decisions are free from influence, all shortlists and winners must be reviewed and signed off by THREE members of a broader awards panel who were not involved in the decision making.
Appendix – Case study examples
Any projects that have expanded the company’s footprint in the sector, including launching in new territories; launching new product lines; acquisition of commercial real estate; acquisition of new machinery; improved logistics; or significant staff increases.
Any steps taken by the company to mitigate the impact of the COVID-19 pandemic on its business and its employees.
Any internal company project to improve diversity in the workforce, this can include changes to hiring policies; graduate and apprenticeship schemes; work groups and societies; and subconscious bias training.
Any projects that have led or will lead to a significant reduction in the company’s carbon footprint. This can include changes to materials and manufacturing, supply chain reviews; reduction in energy use or switches to renewables; recycling initiatives; and carbon offsetting.
Any raising of finance by a company within the sector, this can include corporate lending, and equity and debt capital markets issues including share offers and bond issues. We will be specifically looking at high value deals; novel structures; and companies using (for them) new forms of financing such as high-yield bonds.
Any significant investment into a company; project or asset in the sector by a company, private equity firm or venture capital.
Any public or private acquisition within the relevant sector. We will be specifically looking for deals that are of high value; are likely to have a significant impact in the market; involve a company moving into a new area of business; or deals that are structured in a new or novel way.
Any significant marketing campaign launched during the research period that has led to an increase in revenue or company profile. We will be specifically looking at campaigns introducing new concepts, imagery or taglines and those that demonstrate imagination in their portrayal of the brand.
Product launches and R&D
Research and commercial development of new products and/or new processes. This can include bringing a new product to the marketplace, discovering or creating a unique material, transferring a research or technology development to practice, improving the performance of an existing product or creating a new simulation or design tools.
We will be specifically looking at novelty, including companies launching products into new areas or innovation in the product’s design, manufacture or marketing.
Best practice in health and safety including compliance to standards and any initiatives taken to improve workplace safety through the introduction of new guidelines, policies or equipment.
Social and community initiatives
Any projects that have had a tangible positive impact on the communities where the company operates. This can include anything from charity initiatives; sponsorship; community outreach; local business support and education initiatives.
For more information on the awards and our methodology, please contact:
For Sponsorship Opportunities, please contact: